"Pay For Delay" Legislation Gaining Speed
This article was originally published in The Pink Sheet Daily
Executive Summary
Provision to limit brand/generic settlements is added to health care reform legislation, but section that would forfeit 180-day exclusivity is not.
You may also be interested in...
Brand/Generic Settlement Opponents May Have To Settle For Less
If it's Thursday, S. 369 must be on the agenda
Brand/Generic Settlement Opponents May Have To Settle For Less
If it's Thursday, S. 369 must be on the agenda
Teva Settlements Stick To Date of Entry Even As Legislative Debate Continues
Teva is taking a cautious approach in its patent settlements with brand firms - inking deals that meet the strict standards of pending legislation even as the bills are still under debate